Motif ID: E2f2_E2f5
Z-value: 3.819
Transcription factors associated with E2f2_E2f5:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| E2f2 | ENSMUSG00000018983.9 | E2f2 |
| E2f5 | ENSMUSG00000027552.8 | E2f5 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| E2f2 | mm10_v2_chr4_+_136172367_136172395 | 0.93 | 1.2e-17 | Click! |
| E2f5 | mm10_v2_chr3_+_14578609_14578687 | 0.83 | 2.4e-11 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 13.7 | 41.0 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 10.0 | 70.0 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 8.3 | 83.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 6.6 | 52.5 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 6.3 | 6.3 | GO:0045004 | DNA replication proofreading(GO:0045004) |
| 6.2 | 37.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 5.9 | 23.8 | GO:0006272 | leading strand elongation(GO:0006272) |
| 5.5 | 16.5 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
| 5.2 | 46.9 | GO:0033504 | floor plate development(GO:0033504) |
| 4.7 | 18.6 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
| 4.3 | 39.0 | GO:0090166 | Golgi disassembly(GO:0090166) |
| 4.0 | 20.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 4.0 | 16.0 | GO:0046655 | glycine biosynthetic process(GO:0006545) folic acid metabolic process(GO:0046655) |
| 3.7 | 33.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 3.4 | 47.2 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 3.1 | 9.4 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 2.9 | 8.7 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 2.8 | 48.2 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 2.8 | 11.2 | GO:0061010 | gall bladder development(GO:0061010) |
| 2.8 | 27.6 | GO:1902969 | mitotic DNA replication(GO:1902969) |
| 2.7 | 13.4 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 2.5 | 62.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 2.3 | 6.9 | GO:1904347 | intestine smooth muscle contraction(GO:0014827) regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) regulation of small intestine smooth muscle contraction(GO:1904347) small intestine smooth muscle contraction(GO:1990770) |
| 2.3 | 11.3 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 2.2 | 22.2 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 2.2 | 6.5 | GO:0072554 | blood vessel lumenization(GO:0072554) negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 2.0 | 9.9 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 1.9 | 5.8 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 1.8 | 10.6 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 1.8 | 10.6 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) establishment of Sertoli cell barrier(GO:0097368) |
| 1.8 | 10.6 | GO:0019985 | translesion synthesis(GO:0019985) |
| 1.7 | 8.5 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
| 1.6 | 4.9 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
| 1.6 | 4.9 | GO:0060423 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) negative regulation of mitotic cell cycle, embryonic(GO:0045976) foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of epithelial cell proliferation involved in prostate gland development(GO:0060769) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of histone demethylase activity (H3-K4 specific)(GO:1904173) |
| 1.6 | 4.7 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 1.5 | 7.7 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 1.5 | 8.7 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 1.4 | 5.6 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
| 1.4 | 5.6 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 1.3 | 18.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 1.3 | 6.4 | GO:0019230 | proprioception(GO:0019230) |
| 1.3 | 23.1 | GO:0006312 | mitotic recombination(GO:0006312) |
| 1.2 | 1.2 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
| 1.2 | 3.7 | GO:0048377 | neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) regulation of cardiac ventricle development(GO:1904412) positive regulation of cardiac ventricle development(GO:1904414) |
| 1.2 | 4.9 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
| 1.2 | 8.3 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 1.2 | 16.1 | GO:0072189 | ureter development(GO:0072189) |
| 1.1 | 11.5 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 1.1 | 4.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 1.1 | 58.0 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
| 1.1 | 11.9 | GO:1902916 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) positive regulation of protein polyubiquitination(GO:1902916) |
| 1.0 | 9.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 1.0 | 4.1 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 1.0 | 5.8 | GO:0036337 | Fas signaling pathway(GO:0036337) |
| 0.9 | 2.7 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.9 | 39.7 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
| 0.8 | 2.5 | GO:0045819 | plasmacytoid dendritic cell activation(GO:0002270) positive regulation of glycogen catabolic process(GO:0045819) |
| 0.8 | 2.5 | GO:0070602 | regulation of chondrocyte development(GO:0061181) regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 0.8 | 3.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
| 0.8 | 6.6 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.8 | 2.4 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.8 | 3.9 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.8 | 6.9 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.7 | 3.5 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.7 | 6.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.6 | 5.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.6 | 1.8 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 0.6 | 3.9 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
| 0.5 | 2.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.5 | 2.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.5 | 6.8 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.5 | 5.0 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.5 | 1.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.5 | 1.0 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 0.5 | 9.8 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
| 0.5 | 15.3 | GO:0006284 | base-excision repair(GO:0006284) |
| 0.5 | 7.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.4 | 3.7 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.4 | 3.5 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.4 | 1.2 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.4 | 3.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.4 | 1.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
| 0.4 | 5.4 | GO:0042407 | cristae formation(GO:0042407) |
| 0.4 | 0.7 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 0.4 | 4.7 | GO:0060013 | righting reflex(GO:0060013) |
| 0.4 | 6.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.3 | 1.0 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.3 | 5.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.3 | 4.5 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.3 | 3.5 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.3 | 2.8 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 0.3 | 0.9 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
| 0.3 | 3.8 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.3 | 2.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.3 | 1.4 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) |
| 0.3 | 7.2 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.3 | 2.4 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 0.3 | 0.8 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.3 | 1.0 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
| 0.3 | 15.6 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) |
| 0.2 | 1.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.2 | 5.9 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.2 | 1.8 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
| 0.2 | 1.8 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.2 | 1.5 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.2 | 1.0 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 0.2 | 0.6 | GO:0090204 | protein localization to nuclear pore(GO:0090204) positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.2 | 2.0 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.2 | 5.1 | GO:0007340 | acrosome reaction(GO:0007340) |
| 0.2 | 4.3 | GO:0007099 | centriole replication(GO:0007099) |
| 0.2 | 5.8 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.2 | 3.5 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
| 0.2 | 13.7 | GO:0006342 | chromatin silencing(GO:0006342) |
| 0.2 | 1.8 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.2 | 1.3 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.2 | 2.5 | GO:0043409 | negative regulation of MAPK cascade(GO:0043409) |
| 0.2 | 2.3 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.2 | 3.4 | GO:0021511 | spinal cord patterning(GO:0021511) |
| 0.2 | 1.4 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
| 0.1 | 0.8 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 | 1.4 | GO:0030238 | male sex determination(GO:0030238) |
| 0.1 | 2.1 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 0.1 | 2.0 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
| 0.1 | 0.6 | GO:0030242 | pexophagy(GO:0030242) |
| 0.1 | 1.5 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.1 | 0.9 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.1 | 1.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.1 | 1.7 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
| 0.1 | 2.2 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
| 0.1 | 0.4 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.1 | 2.9 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
| 0.1 | 0.9 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
| 0.1 | 0.2 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.1 | 3.8 | GO:0016925 | protein sumoylation(GO:0016925) |
| 0.1 | 0.4 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.1 | 2.6 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.1 | 1.5 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 | 2.1 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
| 0.1 | 3.0 | GO:0007032 | endosome organization(GO:0007032) |
| 0.1 | 1.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.1 | 3.1 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.1 | 9.9 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
| 0.1 | 2.7 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
| 0.1 | 3.3 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
| 0.1 | 3.2 | GO:0001885 | endothelial cell development(GO:0001885) |
| 0.0 | 0.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.0 | 0.3 | GO:0006983 | ER overload response(GO:0006983) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
| 0.0 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.0 | 0.4 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.0 | 0.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 | 2.2 | GO:0051225 | spindle assembly(GO:0051225) |
| 0.0 | 0.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.0 | 1.0 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
| 0.0 | 1.3 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.0 | 0.1 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
| 0.0 | 5.4 | GO:0007018 | microtubule-based movement(GO:0007018) |
| 0.0 | 0.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.0 | 2.2 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
| 0.0 | 2.5 | GO:0030336 | negative regulation of cell migration(GO:0030336) |
| 0.0 | 1.5 | GO:0007507 | heart development(GO:0007507) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 9.6 | 48.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 5.4 | 26.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 4.6 | 69.4 | GO:0042555 | MCM complex(GO:0042555) |
| 3.6 | 25.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 3.3 | 16.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 2.6 | 13.0 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 2.2 | 20.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 2.1 | 6.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 1.5 | 4.6 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 1.5 | 4.5 | GO:0035061 | interchromatin granule(GO:0035061) |
| 1.5 | 5.9 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 1.5 | 10.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 1.3 | 12.6 | GO:0000796 | condensin complex(GO:0000796) |
| 1.3 | 1.3 | GO:0000811 | GINS complex(GO:0000811) |
| 1.1 | 2.3 | GO:0000801 | central element(GO:0000801) |
| 1.1 | 60.2 | GO:0005657 | replication fork(GO:0005657) |
| 1.1 | 16.5 | GO:0000800 | lateral element(GO:0000800) |
| 0.9 | 6.2 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.8 | 45.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.8 | 10.6 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.7 | 3.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.6 | 3.8 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.6 | 3.8 | GO:0098536 | deuterosome(GO:0098536) |
| 0.6 | 2.4 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 0.6 | 4.9 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.6 | 5.4 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.6 | 37.4 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.6 | 12.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.6 | 3.9 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.5 | 4.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.5 | 1.5 | GO:0031251 | PAN complex(GO:0031251) |
| 0.5 | 51.2 | GO:0005814 | centriole(GO:0005814) |
| 0.5 | 1.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.5 | 2.4 | GO:0001740 | Barr body(GO:0001740) |
| 0.5 | 69.4 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.4 | 6.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.4 | 2.4 | GO:0070187 | telosome(GO:0070187) |
| 0.4 | 24.2 | GO:0000786 | nucleosome(GO:0000786) |
| 0.4 | 4.7 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.4 | 6.0 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.4 | 1.8 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.3 | 1.7 | GO:0001652 | granular component(GO:0001652) |
| 0.3 | 4.4 | GO:0070938 | contractile ring(GO:0070938) |
| 0.3 | 2.2 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.3 | 2.8 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.3 | 70.3 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.3 | 2.9 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.3 | 0.8 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.2 | 2.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.2 | 5.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.2 | 18.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.2 | 0.9 | GO:0032300 | mismatch repair complex(GO:0032300) |
| 0.2 | 0.6 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.2 | 138.9 | GO:0005694 | chromosome(GO:0005694) |
| 0.2 | 10.2 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.2 | 1.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.2 | 2.0 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.1 | 17.2 | GO:0005819 | spindle(GO:0005819) |
| 0.1 | 2.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 1.8 | GO:0036038 | MKS complex(GO:0036038) |
| 0.1 | 3.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.1 | 5.8 | GO:0016605 | PML body(GO:0016605) |
| 0.1 | 3.4 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
| 0.1 | 1.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.1 | 7.0 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.1 | 2.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.1 | 0.4 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.1 | 3.7 | GO:0005901 | caveola(GO:0005901) |
| 0.1 | 2.8 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.1 | 0.6 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.1 | 1.3 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.1 | 4.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.1 | 0.5 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.0 | 0.3 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.0 | 0.7 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.0 | 0.6 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 0.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.0 | 0.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.0 | 126.3 | GO:0005634 | nucleus(GO:0005634) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 13.2 | 79.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 12.3 | 49.3 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 9.6 | 48.2 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 5.3 | 16.0 | GO:0051870 | methotrexate binding(GO:0051870) |
| 3.9 | 15.5 | GO:0036033 | mediator complex binding(GO:0036033) |
| 3.6 | 50.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 3.3 | 23.1 | GO:0000150 | recombinase activity(GO:0000150) |
| 3.1 | 46.3 | GO:0035173 | histone kinase activity(GO:0035173) |
| 2.8 | 8.4 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 2.8 | 8.4 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
| 2.7 | 18.6 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 2.5 | 7.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 2.5 | 12.5 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 2.1 | 14.5 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 1.9 | 11.5 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 1.8 | 20.2 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 1.8 | 7.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 1.4 | 5.6 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
| 1.4 | 11.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 1.4 | 4.1 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
| 1.2 | 38.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 1.2 | 4.9 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 1.2 | 3.6 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
| 1.1 | 27.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 1.0 | 5.9 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
| 1.0 | 7.7 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.9 | 15.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.9 | 6.9 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.8 | 2.5 | GO:0000402 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
| 0.8 | 3.3 | GO:0070279 | vitamin B6 binding(GO:0070279) |
| 0.8 | 5.8 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.7 | 11.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.7 | 8.8 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.7 | 3.5 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.7 | 6.2 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.7 | 5.5 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
| 0.7 | 2.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.6 | 3.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.6 | 16.2 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
| 0.6 | 15.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.5 | 107.2 | GO:0001047 | core promoter binding(GO:0001047) |
| 0.5 | 3.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.5 | 2.4 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.5 | 5.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.5 | 22.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.5 | 5.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.5 | 3.7 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.5 | 37.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.4 | 37.4 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.4 | 16.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.4 | 10.3 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.4 | 5.0 | GO:0031386 | protein tag(GO:0031386) |
| 0.4 | 3.7 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.4 | 1.1 | GO:0032564 | dATP binding(GO:0032564) |
| 0.4 | 2.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.3 | 1.4 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.3 | 2.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.3 | 9.7 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.3 | 1.9 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.3 | 8.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.3 | 23.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.3 | 1.0 | GO:0030983 | mismatched DNA binding(GO:0030983) |
| 0.2 | 5.9 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.2 | 29.4 | GO:0004386 | helicase activity(GO:0004386) |
| 0.2 | 46.8 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
| 0.2 | 2.3 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.2 | 2.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.2 | 65.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.2 | 6.5 | GO:0005112 | Notch binding(GO:0005112) |
| 0.2 | 8.3 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
| 0.2 | 3.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.2 | 0.9 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
| 0.2 | 29.6 | GO:0042393 | histone binding(GO:0042393) |
| 0.2 | 0.9 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.2 | 1.5 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) activin binding(GO:0048185) |
| 0.2 | 10.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.1 | 4.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 1.4 | GO:0008517 | folic acid transporter activity(GO:0008517) |
| 0.1 | 2.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.1 | 0.4 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 0.1 | 0.8 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.1 | 1.8 | GO:0031005 | filamin binding(GO:0031005) |
| 0.1 | 2.6 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.1 | 1.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.1 | 0.4 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 0.1 | 83.2 | GO:0000975 | regulatory region DNA binding(GO:0000975) transcription regulatory region DNA binding(GO:0044212) |
| 0.1 | 3.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.1 | 19.6 | GO:0003682 | chromatin binding(GO:0003682) |
| 0.1 | 3.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.1 | 3.7 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
| 0.1 | 2.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.1 | 1.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.1 | 27.2 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.1 | 0.6 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.1 | 1.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.1 | 2.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.1 | 1.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.1 | 0.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.1 | 2.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.1 | 0.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.1 | 4.8 | GO:0051087 | chaperone binding(GO:0051087) |
| 0.1 | 9.1 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.0 | 1.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.0 | 0.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.0 | 1.7 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 1.0 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.0 | 9.9 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
| 0.0 | 0.6 | GO:0070717 | poly-purine tract binding(GO:0070717) |
| 0.0 | 3.7 | GO:0030674 | protein binding, bridging(GO:0030674) |
| 0.0 | 0.6 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.0 | 0.2 | GO:0048038 | quinone binding(GO:0048038) |
| 0.0 | 2.1 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 8.5 | 76.1 | SA_G2_AND_M_PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 5.6 | 79.1 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 3.3 | 146.0 | PID_ATR_PATHWAY | ATR signaling pathway |
| 1.9 | 150.7 | PID_E2F_PATHWAY | E2F transcription factor network |
| 1.5 | 46.9 | PID_HEDGEHOG_2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.8 | 20.4 | PID_FOXM1_PATHWAY | FOXM1 transcription factor network |
| 0.7 | 37.0 | PID_PLK1_PATHWAY | PLK1 signaling events |
| 0.5 | 23.9 | ST_JNK_MAPK_PATHWAY | JNK MAPK Pathway |
| 0.4 | 5.8 | PID_IL5_PATHWAY | IL5-mediated signaling events |
| 0.4 | 5.8 | SA_PROGRAMMED_CELL_DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.4 | 3.7 | ST_JAK_STAT_PATHWAY | Jak-STAT Pathway |
| 0.4 | 9.3 | PID_CD40_PATHWAY | CD40/CD40L signaling |
| 0.3 | 12.0 | PID_IL4_2PATHWAY | IL4-mediated signaling events |
| 0.3 | 7.4 | PID_BETA_CATENIN_DEG_PATHWAY | Degradation of beta catenin |
| 0.3 | 6.6 | PID_ATM_PATHWAY | ATM pathway |
| 0.2 | 23.3 | PID_MYC_ACTIV_PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.2 | 8.7 | PID_ERBB4_PATHWAY | ErbB4 signaling events |
| 0.2 | 7.8 | PID_ERA_GENOMIC_PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.2 | 6.9 | PID_KIT_PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 1.7 | PID_P38_MKK3_6PATHWAY | p38 MAPK signaling pathway |
| 0.1 | 1.8 | ST_GA12_PATHWAY | G alpha 12 Pathway |
| 0.1 | 4.5 | PID_ILK_PATHWAY | Integrin-linked kinase signaling |
| 0.1 | 2.5 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
| 0.1 | 3.1 | PID_HNF3A_PATHWAY | FOXA1 transcription factor network |
| 0.1 | 3.5 | PID_BMP_PATHWAY | BMP receptor signaling |
| 0.1 | 1.4 | PID_PRL_SIGNALING_EVENTS_PATHWAY | Signaling events mediated by PRL |
| 0.1 | 2.6 | PID_TAP63_PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.1 | 1.1 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
| 0.1 | 3.5 | PID_MET_PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.1 | 2.4 | PID_ARF6_TRAFFICKING_PATHWAY | Arf6 trafficking events |
| 0.1 | 0.6 | PID_RANBP2_PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.0 | 0.9 | SIG_CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.0 | 2.0 | PID_BETA_CATENIN_NUC_PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.0 | 2.3 | PID_NOTCH_PATHWAY | Notch signaling pathway |
| 0.0 | 0.4 | PID_FANCONI_PATHWAY | Fanconi anemia pathway |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 9.2 | 184.5 | REACTOME_G1_S_SPECIFIC_TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 8.8 | 96.6 | REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 5.5 | 76.5 | REACTOME_UNWINDING_OF_DNA | Genes involved in Unwinding of DNA |
| 4.1 | 36.6 | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 2.6 | 44.4 | REACTOME_G0_AND_EARLY_G1 | Genes involved in G0 and Early G1 |
| 2.5 | 9.9 | REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 2.3 | 16.4 | REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND | Genes involved in Processive synthesis on the lagging strand |
| 2.2 | 30.2 | REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 1.6 | 18.8 | REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 1.2 | 7.2 | REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR7_8_OR_9_STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 1.2 | 32.1 | REACTOME_KINESINS | Genes involved in Kinesins |
| 0.7 | 4.9 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.6 | 6.6 | REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.5 | 45.0 | REACTOME_MEIOSIS | Genes involved in Meiosis |
| 0.5 | 13.0 | REACTOME_G1_PHASE | Genes involved in G1 Phase |
| 0.5 | 9.2 | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.4 | 6.7 | REACTOME_ERKS_ARE_INACTIVATED | Genes involved in ERKs are inactivated |
| 0.4 | 6.5 | REACTOME_SIGNALING_BY_NOTCH4 | Genes involved in Signaling by NOTCH4 |
| 0.3 | 61.8 | REACTOME_SIGNALING_BY_RHO_GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.3 | 5.6 | REACTOME_PURINE_SALVAGE | Genes involved in Purine salvage |
| 0.3 | 10.2 | REACTOME_RNA_POL_I_TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
| 0.3 | 6.9 | REACTOME_REGULATION_OF_KIT_SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.3 | 1.6 | REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.2 | 6.0 | REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.2 | 2.7 | REACTOME_PLATELET_SENSITIZATION_BY_LDL | Genes involved in Platelet sensitization by LDL |
| 0.2 | 3.7 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.2 | 3.2 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.2 | 4.5 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.2 | 4.7 | REACTOME_STRIATED_MUSCLE_CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.1 | 4.9 | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.1 | 5.8 | REACTOME_MRNA_3_END_PROCESSING | Genes involved in mRNA 3'-end processing |
| 0.1 | 3.5 | REACTOME_SIGNALING_BY_BMP | Genes involved in Signaling by BMP |
| 0.1 | 8.7 | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.1 | 6.1 | REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.1 | 0.6 | REACTOME_REGULATION_OF_IFNG_SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.1 | 1.7 | REACTOME_SIGNALING_BY_HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 0.5 | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.1 | 0.9 | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.1 | 4.1 | REACTOME_MITOTIC_PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.0 | 12.0 | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.0 | 1.5 | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.0 | 0.4 | REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_ | Genes involved in Cleavage of Growing Transcript in the Termination Region |
| 0.0 | 3.5 | REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.0 | 1.0 | REACTOME_EGFR_DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.0 | 0.4 | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.0 | 0.5 | REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
|
|
|